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Abstract
Lethal toxin (LT) is a critical virulence factor of Bacillus anthracis, the etiological agent of anthrax, whose pulmonary form is
fatal in the absence of treatment. Inflammatory response is a key process of host defense against invading pathogens. We
report here that intranasal instillation of a B. anthracis strain bearing inactive LT stimulates cytokine production and
polymorphonuclear (PMN) neutrophils recruitment in lungs. These responses are repressed by a prior instillation of an LT
preparation. In contrast, instillation of a B. anthracis strain expressing active LT represses lung inflammation. The inhibitory
effects of LT on cytokine production are also observed in vitro using mouse and human pulmonary epithelial cells. These
effects are associated with an alteration of ERK and p38-MAPK phosphorylation, but not JNK phosphorylation. We
demonstrate that although NF-kB is essential for IL-8 expression, LT downregulates this expression without interfering with
NF-kB activation in epithelial cells. Histone modifications are known to induce chromatin remodelling, thereby enhancing
NF-kB binding on promoters of a subset of genes involved in immune response. We show that LT selectively prevents
histone H3 phosphorylation at Ser 10 and recruitment of the p65 subunit of NF-kB at the IL-8 and KC promoters. Our results
suggest that B. anthracis represses the immune response, in part by altering chromatin accessibility of IL-8 promoter to NF-
kB in epithelial cells. This epigenetic reprogramming, in addition to previously reported effects of LT, may represent an
efficient strategy used by B. anthracis for invading the host.
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Introduction
Pulmonary infection by B. anthracis, the etiologic agent of
anthrax disease [1], has been shown to be the most life-threatening
form of the disease as compared to gastrointestinal and cutaneous
forms of anthrax. Whatever the infection route used by this
bacterium, spores are taken up by macrophages and/or dendritic
cells, and subsequently migrate in the draining lymph nodes where
they germinate [2,3]. Germination leads to bacterial multiplication
and dissemination through the whole organism. Despite a
therapeutic intervention, all forms of infection may progress to
fatal systemic anthrax, which is characterized by shock-like
symptoms, sepsis, and respiratory failure [4]. Therefore, investi-
gation of the immune response triggered by B. anthracis may help to
better understand the pathophysiology of anthrax and to develop
efficient therapeutic approaches for the treatment of this disease.
The innate immune response, including the inflammatory
reaction that is the first line of host defense against invading
pathogens, is characterized by upregulation of various inflammatory
genes due to the activation of transcription factors. IL-8 (Inter-
leukine-8, CXCL8) is a human chemokine that induces the
recruitment of polymorphonuclear (PMN) neutrophils from the
blood to the injured tissue [5]. This allows PMN to eradicate the
invading pathogenwithinthe site ofinfection.Inhealthytissues,IL-8
is barely detectable, but is rapidly induced by nuclear factor kB( N F -
kB) and activator protein 1 (AP-1)-dependent inflammatory stimuli
suchasTNFa,bacteriaorvirus[6].Recently,significant advancesin
the understanding of signaling pathways, which regulate IL-8
transcription as well as mRNA stabilization in response to external
stimuli, have been made [6]. It is now clearly established that
induction of inflammatory genes is associated with local changes in
histone modification that plays a major role in epigenetic regulation
of gene expression. The core histones including H2A, H2B, H3 and
H4 are the basic components of the nucleosomes that organize the
cellular DNA in chromatin [7,8]. Covalent modifications of the
histones play a major role in gene regulation by affecting chromatin
compaction and thereby DNA accessibility. These modifications can
result in either transcriptional repression (like for H3me3K9 and
H3me1K27) or activation (H3me3K4, H3pS10 and acetylation at
various positions) [9,10].
The exact mechanisms by which B. anthracis induces anthrax
disease are not fully understood; however, it is clearly established
that this bacterium spreads rapidly into the host at the early stages
of infection with low or no detectable immune response [2,11,12].
This is likely due to the ability of B. anthracis to subvert the host
immune response [11–13] via, at least in part, the action of tow
major toxins, edema toxin and lethal toxin (LT). B. anthracis
secretes a transporter called protective antigen (PA) which acts in
pair with lethal factor (LF) leading to the formation of lethal toxin
(LT). LT cleaves MAPKK thereby interfering with MAPK
PLoS Pathogens | www.plospathogens.org 1 April 2009 | Volume 5 | Issue 4 | e1000359cascade [14,15] a process known to play a major role in
pathogenesis of anthrax. However, the molecular mechanisms
that may link MAPK inhibition by LT and modulation of target
gene expression remained unclear.
We report here that LT impaired the inflammatory response in
a mouse model of pulmonary anthrax. Remarkably, LT repressed
IL-8 expression without interfering with NF-kB activation, an
essential transcription factor for IL-8 expression. Investigation of
the molecular mechanisms involved in this inhibition revealed that
LT blocked histone (H3) phosphorylation at serine 10, a
modification normally induced by activation of the MAPK
pathway and that is also involved in chromatin accessibility for
NF-kB. This epigenetic reprogramming is probably a key
mechanism by which B. anthracis circumvents the immune response
during the earlier stage of infection.
Results
LT impairs B. anthracis–induced lung inflammatory
response
We examined the effect of B. anthracis on lung inflammation in a
mouse model of pulmonary anthrax and the contribution of LT to
this effect. All strains used in this study were in bacilli form. The
degree of inflammatory reaction was assessed by measuring the
recruitment of polymorphonuclear (PMN) leukocyte, and the
levels of proinflammatory cytokines interleukin-6 (IL-6) and KC
(mouse functional orthologue of human IL-8) in broncho-alveolar
lavage fluids (BALFs). Intranasal instillation of the RPLC2 strain
(producing inactive LT) induced an increase of IL-6 and KC levels
(Figure 1A) and PMN recruitment (Figure 1B), in contrast to the
RP9 strain (producing active LT) which had no effect. Intratra-
cheal instillation of LT to mice before bacterial administration
impaired RPLC2-induced increases of IL-6 and KC levels
(Figure 1A) and PMN recruitment (Figure 1B). Intranasal
instillation of LPS (instead of bacteria) induced an increase in
concentrations of MIP-2, KC and IL-6 levels (Figure 1C) and
PMN recruitment (Figure 1D). All these responses were abrogated
by intratracheal instillation of LT before LPS.
LT modulates cytokine expression by lung epithelial cells
These findings led us to examine the effect of LT on the in vitro
secretion of cytokines by primary cells isolated from mouse lungs.
LT blocked LPS-induced KC and IL-6 secretions by primary
epithelial cells (Figure 2F) and MIP-2, KC and IL-6 secretions by
alveolar macrophage (AMs) (data not shown).
We next investigated in more details the effects of LT on
cytokine production in a human epithelial cell line Beas-2B. The
RPLC2 strain induced IL-8 secretion by Beas-2B cells in contrast
to the RP9 strain (Figure 2A). The RP9 strain inhibited TNFa-
induced IL-8 secretion, whereas the RPLC2 strain had no effect
(Figure 2B). LT blocked TNFa-induced IL-8 mRNA expression
(Figure 2C), IL-8 (Figure 2D) and IL-6 (Figure 2E) secretions.
Inhibition of IL-8 secretion by LT was also observed when Beas-
2B cells were stimulated by IL-1b or LPS instead of TNFa (data
not shown).
Inhibition of IL-8 expression by LT is not due to an
alteration of NF-kB activation/translocation
As NF-kB is a key transcription factor of inflammatory gene
expression including IL-8 [8], we examined its implication in IL-8
expression in our cell system. We analyzed IL-8-promoter
activation in Beas-2B cells transfected with the (2133 pb) IL-8-
promoter or an [DNF-kB] IL-8 promoter in which the responsive
elements of NF-kB were mutated. TNFa induced the activation of
the (2133 pb) IL-8-promoter but failed to stimulate the activation
of the [DNF-kB] IL-8 promoter (Figure 3A). Preincubation of cells
with BAY, an NF-kB inhibitor, abrogated TNFa-induced IL-8
secretion (Figure 3B). These findings indicated that NF-kBi s
essential for IL-8 expression in Beas-2B cells. The use of the [DAP-
1] and [DNF-IL6] IL-8 promoter showed that AP-1 and NF-IL6
are only marginally involved in the induction of the IL-8
expression by TNFa (data not shown).
These findings led us to examine whether inhibition of IL-8
expression by LT is due to an alteration of NF-kB activation. Our
results showed that neither LT nor MAPK inhibitors inhibited
TNFa induced NF-kB activation or translocation. MAPK
inhibitors even enhanced this activation (Figure 3C and 3D).
LT inhibits IL-8 expression via a MAPK-dependent
pathway
MAPK cascade is known to modulate IL-8 expression in various
cell systems [8]. This was confirmed in the present study using
SB202190 and PD98059, specific inhibitors of p38-MAPK and
ERK, respectively. Indeed, pre-treatment of Beas-2B cells with
these compounds, significantly reduced TNFa-induced IL-8
expression (Figure 4B). We also showed that LT cleaves MEK1,
MEK2, MEK3 in these cells (Figure 4C), a finding in agreement
with the know ability of LT to cleave MAPKKs [14,15]. LT
inhibited TNFa-induced ERK and p38-MAPK phosphorylation,
but had no effect on JNK phosphorylation (Figure 4A). Studies on
Beas-2B cells transfected with the IL-8 promoter reporter plasmid
showed that LT and MAPK inhibitors had no effect on TNFa-
induced IL-8 promoter activity (Figure 4D), which contrasted with
the ability of these compounds to inhibit the expression of
endogenous IL-8. We next examined the effect of LT on the
activation of mitogen and stress-activated kinases (MSK), located
down-stream MAPKK pathways, and involved in histone
phosphorylation. Incubation of Beas-2B cells with TNFa increased
the level of MSK2 phosphorylation which was reduced by pre-
treating cells with LT (Figure 4E). No detectable expression of
MSK1 or phospho-MSK1 was observed in these cells (data not
shown).
Author Summary
Bacillus anthracis, the etiological agent of anthrax, can
infect mammals either accidentally or as a potential
consequence of a terrorism threat. Pulmonary infection is
a life-threatening form of the disease, causing a near 100%
mortality rate in the absence of appropriate therapy. Thus,
it is important to understand the mechanisms of host
defense against B. anthracis. We examined the effects of
various B. anthracis strains on lung inflammation in a
mouse model of pulmonary anthrax and on human lung
epithelial cells, the first barrier of lung against invading
pathogens. We showed that a B. anthracis strain express-
ing lethal toxin inhibits inflammation. In contrast, a strain
in which this toxin has been inactivated induces lung
inflammation. We next examined the mechanisms in-
volved in the inhibitory effect of lethal toxin. We showed
that B. anthracis injects lethal toxin into epithelial cells,
blocks the molecules associated on the chromosome, and
thus represses production of mediators involved in
inflammation. As the latter is a key process in host
defense, its alteration by lethal toxin predisposes the host
to infection by B. anthracis. This effect on the chromo-
somal machinery may represent an efficient strategy used
by B. anthracis for invading the host.
Epigenetic Reprogramming by B. anthracis
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KC promoter accessibility
The results above suggested that LT inhibited IL-8 expression, at
a site probably located down-stream of NF-kB activation/translo-
cation and depending onMAPKcascade. This led usto examine the
effect of LT on the phosphorylation of H3, known to promote the
accessibility of NF-kB to target promoters [5–8]. Western blot and
immunofluorescence analyses showed that LT suppressed TNFa-
induced H3 phosphorylation at Ser10 and acetylation at Lys14
(Figure 5A and 5B) in Beas-2B cells, suggesting that LT can impair
the chromatin accessibility of NF-kB at the IL-8 promoter. We
stimulated Beas-2B by TNFa with or without LT and then carried
out chromatin immunoprecipitation (ChIP) assays using an antibody
against p65 subunit of NF-kB, RNAPII antibodies or using an
irrelevant immunoglobulin G (IgG) of the same isotype as a control.
ChIP analyses showed that LT suppressed TNFa-induced p65 and
RNAPII recruitment to the IL-8 promoter while no effect was
observedinthe recruitment attheGAPDH promoter(Figure 6A).In
addition, the results showed that TNFa induced phosphorylation at
Ser10 and acetylation at Lys14 of histone H3 on the IL-8 promoter
whereas the other modifications on H3 were not significantly
regulated. LT abrogated TNFa-induced presence of di-modified
histone H3 phosphorylated at Ser10 and acetylated at Lys14 at the
IL-8 promoter (Figure 6B). Acetylation at Lys9 and tri-methylation
at Lys4 (known to reflect positive modulation of transcription) were
not modified on the IL-8 promoter in our experimental conditions.
Tri-methylation at Lys9, which generally correlates with inhibition
of transcription, occurred in parallel to tri-methylation at Lys4
(Figure 6B).
We next performed ChIP analyses on a mouse epithelial cell
line MLE-15 to examine the effect of LT on the KC promoter. We
verified that LT inhibited TNFa-induced KC expression in these
cells (data not shown). We observed almost similar regulations of
histone modifications in this promoter (Figure 7). The weaker
effects on KC versus IL-8 of the TNFa treatment on the H3pS10
and AcK14 modifications could be explained partially by the fact
that the KC promoter appears to contain more H3me3K4 than
the IL-8 promoter (160% of H3 versus 40% of H3, respectively),
suggesting that the KC promoter chromatin could be in a more
opened configuration than the IL-8 one.
Figure 1. LT impairs pulmonary inflammatory response. (A,B) Mice received intratracheal instillation of LT (550 mg/kg) or saline 1 h before
intranasal instillation of germinated RP9 or RPLC2 bacilli (10
7 cfu). Sixteen hours later, BALs were performed, then KC and IL-6 concentrations (A), and
the numbers of PMN neutrophils (B) were measured. (C,D) Mice received intratracheal instillation of LT (550 mg/kg) or saline 1 h before intranasal
instillation of LPS (330 mg/kg). Sixteen hours later, BALs were performed, and the concentrations of MIP-2, KC, and IL-6 (C) and numbers of PMN
neutrophils (D) were determined.
doi:10.1371/journal.ppat.1000359.g001
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Pulmonary anthrax is an acute disease of animals and humans
caused by inhalation of spores of pathogenic strains of B. anthracis
[1–3]. Upon infection, the spore germinates and begins to outgrow
into toxin-producing replicating bacilli, which can ultimately kill
the infected host [2,11,12]. LT, a major virulence factor of B.
anthracis, has been shown to play a key role in the pathophysiology
of anthrax and associated mortality [11,12]. We demonstrated
here that B. anthracis represses the mouse pulmonary inflammatory
response (PMN recruitment and cytokine production) and that LT
plays a key role in this inhibition. Moreover, in the absence of LT,
B. anthracis induces this response, which suggests that component(s)
of this bacterium is (are) able to induce an inflammatory reaction,
and that their action is masked by the inhibitory effect of LT. This
is consistent with previous studies, which have reported that B.
anthracis spores stimulate cytokine production in various cells [16–
18]. Our recent study showed that peptidoglycan, a constitutive
cell wall component of B. anthracis, induces type-IIA secreted
phospholipase A2 expression in AMs through a NF-kB dependent
process [13]. In the earlier stages of infection, inhaled spores
trigger an inflammatory response that is subsequently repressed as
soon as LT is produced by outgrowing bacilli. Therefore, it was of
a great interest to identify the molecular mechanisms by which LT
represses the expression of genes involved in the inflammatory
response.
Early studies demonstrated that phosphorylation of histones at
specific amino acid residues regulates gene transcription [7–10].
The present study suggested that B. anthracis targets chromatin
access for transcription factors, which may alter gene transcription.
LT has been shown to suppress cytokine production by a process
involving the disruption of MAPKKs [11,12], yet the molecular
Figure 2. LT modulates cytokine expression by epithelial cells. (A,B) Beas-2B cells were infected with the B. anthracis strains RP9 and RPLC2 at
an MOI of 20:1 for 3 h in the absence of antibiotics. Cells were then washed and incubated in a medium supplemented with antibiotics in the
absence (A) or presence (B) of TNFa. After 24 h incubation, supernatants were collected and IL-8 concentrations were measured. (C,D) Beas-2B cells
were pretreated with LT (PA+LF) for 1 h before stimulation with TNFa (10 ng/ml). A fixed concentration of PA (1 mg/ml) and increasing
concentrations of LF were used. After 24 h incubation, IL-8 mRNA expression (C) and IL-8 secretion (D) were measured. (E) Beas-2B cells were
pretreated with LT (1 mg/ml) for 1 h before stimulation with TNFa (10 ng/ml), and IL-6 concentrations were measured after 24 h incubation. (F)
Epithelial cells were isolated from lungs of naive mice and pretreated with LT (1 mg/ml) for 1 h before incubation with LPS (1 mg/ml). KC and IL-6
secretions were measured after 24 h stimulation.
doi:10.1371/journal.ppat.1000359.g002
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inflammatory genes remained to be elucidated. We reported here
for the first time that inhibition of cytokine production in epithelial
cells by LT occurs via a process involving an alteration of histone
H3 phosphorylation/acetylation. Histone modification such as
phosphorylation of H3 and acetylation of lysine on histones H3 or
H4 can be associated with transcriptional activation [19–22].
Indeed, gene expression occurs when the chromatin is in the
opened conformation that is promoted in part by histone
phosphorylation. Moreover, phosphorylation of H3 is mediated,
in part, by mitogen and stress-activated kinase (MSK), which is
activated by MAPK (p38-MAPK and ERK) signaling pathways
[22,23]. Our findings showed that LT blocked the activation of
p38-MAPK and ERK (as a consequence of MAPKK cleavage by
LT) and that this inhibition led to the alteration of histone H3
phosphorylation through a process involving an inhibition of
MSK2 phosphorylation. Indeed, MSK2 has been shown to
mediate histone H3 phophorylation [22,23].
The present study shows that both MAPK and NF-kB pathways
are essential for IL-8 expression in Beas-2B cells. These results are
consistent with previous reports showing that these pathways play
a major role in the induction of IL-8 expression in various cell
systems [6]. Our results showed that NF-kB activation in Beas-2B
cells occurred via a MAPK-independent process. This led us to
Figure 3. LT inhibits IL-8 expression through a process independent of NF-kB activation. (A) Beas-2B cells were transfected with IL-8
promoter (2133 pb) or [DNF-kB] IL-8 promoter reporter plasmids before stimulation with TNFa (10 ng/ml). Luciferase activity was measured after
24 h stimulation. (B) Cells were pretreated with BAY (10 mM) for 1 h and stimulated with TNFa (10 ng/ml). IL-8 concentrations were measured in
supernatants after 24 h stimulation. (C) Cells were pretreated for 1 h with LT (1 mg/ml), SB203580, or PD98059 and incubated with TNFa (10 ng/ml).
NF-kB luciferase activity was analysed after 24 h stimulation. (D) Cells were pretreated with LT (1 mg/ml), SB203580 (10 mM), or PD98059 (10 mM) and
then stimulated with TNFa (10 ng/ml) for an additional 2 h. NF-kB translocation was analysed by EMSA.
doi:10.1371/journal.ppat.1000359.g003
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modulate IL-8 expression. Our results suggested that epigenetic
remodeling initiated by MAPK-induced H3 phosphorylation
promotes the accessibility of IL-8 promoters to NF-kB, thereby
enhancing IL-8 expression. This process seems also to play a role
in the modulation of KC promoter activity, the mouse functional
orthologue of human IL-8 promoter. This epigenetic modulation,
which is in part under the control of MAPKs, may occur only in
the chromatin context whose remodeling favors the recruitment of
transcription machinery components including NF-kB. This may
explain why MAPK inhibition failed to interfere with the
activation of the transfected IL-8 promoter reporter construct,
which is not in the context of chromatin and therefore cannot be
modulated via a MAPK-dependent epigenetic remodeling. Our
results are in agreement with the recent study of Arbibe et al [24]
showing that OspF, a virulence factor of Shigella flexneri endowed
Figure 4. LT inhibits IL-8 expression via a MAPK-dependent pathway in Beas-2B cells. (A) Beas-2B cells were incubated for 1 h with LT
(1 mg/ml) and stimulated with TNFa (10 ng/ml) for an additional 2 h. Western blot analyses were performed using antibodies directed against ERK,
phospho-ERK (ERKpT202-Y204), p38, phospho-p38 (p38pT180-Y182), JNK, and phospho-JNK (JNKpT183-Y185) and were normalized with ß-actin
antibody. (B) Cells were pretreated with SB203580 (10 mM) or PD98059 (10 mM) for 1 h before incubation with TNFa (10 ng/ml). IL-8 concentrations
were measured in supernatants after 24 h stimulation. (C) Cells were incubated for 1 h with LT (1 mg/ml) and stimulated by TNFa (10 ng/ml) for an
additional 2 h. Western blot analyses were performed using antibodies directed against MEK-1, MEK-2, and MEK-3 and were normalized with ß-actin
antibody. (D) Cells were transfected with an IL-8 promoter reporter plasmid, and then incubated for 1 h with LT (1 mg/ml), SB203580 (10 mM), or
PD98059 (10 mM) before addition of TNFa (10 ng/ml). Luciferase activity was then measured after 24 h stimulation. (E) Cells were incubated for 1 h
with LT (1 mg/ml) and stimulated by TNFa (10 ng/ml) for an additional 45 min. Western blot analyses were performed using antibodies directed
against MSK-2 and phospho-MSK-2 and normalized with ß-actin antibody.
doi:10.1371/journal.ppat.1000359.g004
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limited subset of gene promoters, including IL-8 promoter, which
then become inaccessible to NF-kB. Although both S. flexneri and
B. anthracis downregulate inflammatory gene expression, they
clearly interfere with H3 phosphorylation at different levels: S.
flexneri acts downstream H3 phosphorylation by dephosphorylating
ERK p38-MAPKs once they translocate into nucleus whereas B.
anthracis blocks this process upstream these MAPKs by a cleavage
of MAPKKs in the cytosol. However, it should be noted that, in
addition to its epigenetic effect on the transcriptional activity of the
IL-8 promoter, LT can also inhibit IL-8 expression via
destabilization of IL-8 mRNA [25].
Recent studies have shown that lung epithelial cells interact with
B. anthracis suggesting that these cells may play a role in host
defense against pulmonary anthrax. Indeed, B. anthracis spores are
taken up by lung epithelial cells either in vitro [26] and in vivo [27]
and this uptake is followed by entry and germination of spores,
though with low efficiency [26]. AMs and dendritic cells are also
known to participate in host defense against inhaled B. anthracis,
and play a role in spore uptake and germination [2,3].
Interestingly, recent reports showed that spore germination and
bacterial growth occurred at the site of entry, i.e. nasopharynx and
alveoli [28–31]. Thus, available data suggest that spore germina-
tion, initial bacterial multiplication and lung epithelium crossing
may occur along the respiratory tract. The respective role of each
cell population still remains to be evaluated in vivo, in particular
whether efficiency in spore uptake is paralleled with efficient
dissemination from the lung. On the other hand, inhibition by
toxins of the inflammatory response initiated by lung epithelial
cells may favor the implication of AMs and dendritic cells in
subsequent dissemination at later stages of the disease. Moreover,
induction of cytokine production by epithelial cells has been shown
to occur through a MAPK-dependent pathway [32]. Another
report [33] showed that bronchial epithelial cells highly expressed
TEM8, a receptor of B. anthracis toxins, thus confirming the
implication of these cells in host response to B. anthracis. Lung
epithelial cells have been shown to contribute to the innate
immune response after interaction with pathogens such as virus
[34] and bacteria [35]. Given the role of lung epithelial cells as an
important source of chemokines (including IL-8), the inhibition of
their activation by LT may have a critical impact on PMN
recruitment, and therefore would compromise host defense against
inhaled B. anthtacis. Indeed, a previous study showed that PMN
play a role in host defense in pulmonary anthrax since PMN-
depleted mice exhibited higher mortality by inhalation of B.
anthracis [36]. Although lung epithelial cells could play a role
during the activation of immune response in the early steps of
anthrax infection, it should be, however, kept in mind that other
pulmonary cell types such AMs, whose cytokine production is
repressed by LT (our unpublished data), may contribute to the
inhibitory effect of LT on lung IL-8/KC production.
In conclusion, we report here that B. anthracis represses the
expression of cytokines such as IL-8 in epithelial cells. This
inhibition occurs through a process involving LT-mediated
epigenetic reprogramming, and might represent a novel mecha-
nism by which this bacterium can evade the host innate immune
response. This reprogramming would take place following spore
germination and may compromise pulmonary host defense leading
to bacterial proliferation and ultimate host death. Therefore, the
use of pharmacological approaches to inhibit LT may represent a
potential therapeutic strategy for the treatment of anthrax.
Materials and Methods
Animals and reagents
F-12K nutrient mixture, antibiotics, glutamine, Hanks’ Bal-
anced Salt Solution, Alexa FluorH 488 F(ab9) fragment of goat
anti-rabbit IgG (H+L) were from Invitrogen (Cergy-Pontoise,
France). Fetal calf serum was from PAA (Etobicoke, USA).
(TLRgrade
TM) LPS from E. coli (Serotype 0111:B4) was from Alexis
Biochemicals (San Diego, USA). Human b-actin antibody was
from Sigma Aldrich (St. Louis, USA). SB203580 was from Tebu-
bio (Le Perray, France). Antibodies against histone H2B (ab1790),
histone H3 (ab1791), acetyl-histone H3 (H3AcK9, ab4441),
methyl-histone H3 (H3me3K4, ab8580) and (H3me3K9,
ab8898) and MSK-2 (ab42101) were from Abcam (Cambridge,
USA). Antibodies against phospho-histone H3 (H3pS10, 05-817)
and phospho-acetyl-histone H3 (H3pS10-AcK14, 07-353) were
from Upstate Cell Signaling (New York, USA). Antibodies against
RNA Polymerase II (RNAPII, sc-899), MEK-1 (sc-219), MEK-3
Figure 5. LT impairs H3 phosphorylation. Beas-2B cells were
incubated for 1 h with LT (1 mg/ml) and stimulated with TNFa (10 ng/
ml) for an additional 2 h. Western blot analyses were performed using
H3, H3pS10, and H3pS10-AcK14 antibodies and were normalized with a
b-actin antibody (A). Immunofluorescence analyses were performed
using an H3pS10 antibody and DAPI (B).
doi:10.1371/journal.ppat.1000359.g005
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Cruz (Santa-Cruz, USA). Antibodies against MEK-2 (9125), p38-
MAPK (9212), phospho-p38-MAPK (p38pT180-Y182, 9211),
ERK (9102), phospho-ERK (ERKpT202-Y204, 9101), JNK
(9252) and phospho-JNK (JNKpT183-Y185, 4668) and
PD98059 were from Cell Signaling (Danvers, USA). Antibody
against phospho-MSK-2 (Ser196), human and mouse recombi-
nant TNFa were from R&D systems (Minneapolis, USA).
Recombinant Lethal Factor (LF) and Protective Antigen (PA)
from B. anthracis were from List Biological lab (Campbell, USA).
Human bronchial epithelial cell line Beas-2B was from the
American Type Cell Collection (Rockville, USA). Mouse alveolar
epithelial cell line MLE-15 was a gift from Dr. J.A. Whitsett
(Cincinnati Children’s Hospital Medical Center, Cincinnati,
USA). 7 weeks old C57/BL6 mice were supplied by the Centre
d’Elevage R. Janvier (Le Genest Saint-Isle, France). Mice were
cared for in accordance with Pasteur Institute guidelines, in
compliance with the European Animal Welfare regulations.
B. anthracis strains
The following isogenic non-capsulated B. anthracis strains were
studied: the single mutant RP9 that produces active LF and
inactive EF, and the double-mutant RPLC2 producing inactive LF
and inactive EF. Both mutants produce functional PA [37].
Mouse treatments
Mice were anesthetized by i.p. injection of a mixture of
ketamine-xylazine as previously described [38] before intranasal
instillation of 50 ml of bacilli (10
7 cfu) or LPS (330 mg/kg). In
certain experiments, anesthetized mice received intratracheal
Figure 6. LT impairs IL-8 promoter accessibility. Beas-2B cells were incubated for 1 h with LT (1 mg/ml) and stimulated with TNFa (10 ng/ml)
for additional 45 min. Cells were fixed with formaldehyde and then chromatin sonicated. The relative recruitment of NF-kB-p65 (p65) and the RNAPII
(RNA Polymerase II) ChIP were expressed relative to the non-immun IgG rabbit used as a negative control (A). The H2B and the H3 histone tail
modifications ChIP were reported to the H3 ChIP and expressed in percentages (B). Each value was corrected for the recruitment of each antibody on
the CD44 exon 2 region used as an unregulated control gene by the TNFa and the LT. Note that the H2B signal relative to H3 is constant upon
treatment and the promoters. It was three times more important than H3, probably because of the relative efficiency of antibodies.
doi:10.1371/journal.ppat.1000359.g006
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per Kg) 1 h before instillation of LPS or bacilli. Nascent bacilli
were recovered from a 90 min growth in R medium as previously
described [28].
Incubation of cells with bacteria, toxins, and drugs
Epithelial cells isolated from lung homogenates as previously
described [39,40], Beas-2B and MLE-15 cell lines were pretreated
with LT (PA+LF), PD98059, SB203580, or BAY for 1 h before
incubation with LPS or TNFa at the concentrations and durations
indicated in the figure legends. In other experiments, 1 h after
addition of drugs or LT, Beas-2B cells were infected with bacilli for
3 h in the absence of antibiotics, washed and re-incubated for
additional 24 h in a medium supplemented with antibiotics.
Cytokine enzyme immunoassays and PMN counts
IL-8, KC, IL-6 and MIP-1 concentrations were measured in
culture medium or in BALs using DuoSet ELISA kits from R&D
systems (Minneapolis, USA). Total cell counts in BALs were
determined with a Coulter Counter from Coulter Electronics
(Margency, France), and differential cell counts were determined
after cytospin centrifugation and staining with Diff-Quick
products.
Protein extraction and Western blot analyses
Proteins were extracted from Beas-2B cells using RIPA and then
20 mg of total proteins were subjected to SDS-PAGE. Proteins
were transferred to membrane from Millipore (Billerica, USA),
which were blocked and probed for 1 h with the indicated
Figure 7. LT impairs KC promoter accessibility. MLE-15 cells were incubated for 1 h with LT (1 mg/ml) and stimulated with TNFa (10 ng/ml) for
an additional 45 min. Cells were fixed with formaldehyde and then chromatin sonicated. The relative recruitment of NF-kB-p65 (p65) and the RNAPII
(RNA Polymerase II) ChIP were expressed relative to the non-immun IgG rabbit used as a negative control (A). The H2B and the H3 histone tail
modifications ChIP were reported to the H3 ChIP and expressed in percentages (B). Each value was corrected for the recruitment of each antibody on
the CD44 exon 2 region used as an unregulated control gene by TNFa and LT. Note that the H2B signal relative to H3 is constant upon treatment and
the promoters. It was two times more important than H3, probably because of the relative efficiency of antibodies.
doi:10.1371/journal.ppat.1000359.g007
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visualized with a specific peroxidase-conjugated anti-immunoglob-
ulin G (IgG) antibody and using an ECL Plus Western Blotting
Detecting System (Amersham, Biosciences).
Nuclear protein extraction and Electrophoretic Mobility
Shift Assays
Nuclear proteins were extracted from Beas-2B cells, as previously
described [41]. The NF-kB double-stranded oligonucleotides (Santa
Cruz Biotechnology) 59-AGT TGA GGG GAC TTTT CCC AGG
C-3 c-
32P-labeled with T4 polynucleotide kinase (Biolabs) were
incubated for 20 min at room temperature, with 5 mg of nuclear
extract, 10 ml of binding buffer (40 mM HEPES (pH 7), 140 mM
KCl,4 mMDTT,0.02%NonidetP-40,8%Ficoll,200 mg/ml BSA,
1 mg of poly(dI:dC). Migration was performed on a 5% polyacryl-
amide gel in 0.5% Tris/borate/EDTA buffer at 150 V for 2 h. Gels
were dried and exposed for 2 to 12 h.
Immunofluorescence analysis
Beas-2B cells were fixed for 10 min with 3.7% (weight/volume)
paraformaldehyde in PBS and then were permeabilized with 0.5%
(volume/volume) Triton-X 100 in PBS. Fixed cells were treated
1 h with the indicated primary antibodies.
Transfection studies
Beas-2B cells were cultured in 24 well plates, at 70% confluence
and transfected with an IL-8 promoter construct [133]-Luc, an [D
NF-kB] IL-8 promoter construct mutated on NF-kB site or a NF-
kB construct-Luc. After indicated treatment, luciferase activity was
measured using a luciferase reporter assay kit, with signal detection
for 12 s by a luminometer (Berthold, Pforzheim, Germany),
RNA extraction and real time Reverse-Transcription PCR
analysis
Total RNA was extracted using an RNeasy kit from Qiagen
(Courtaboeuf, France). DNase treatment was performed using 2 mg
of extracted RNA, 1 ml of DNase I (Amersham Biosciences, Orsay,
France), and 0.5 ml of RNasin (Promega, Madison, WI) in a total
volume of 20 ml in the manufacturer’s buffer. cDNA were obtained
by incubating RNA with 1 mM dNTP (Eurobio, Les Ulis, France),
1.5 ml of hexamers as primers, 20 units of RNasin (Promega,
Madison, WI), and 300 units of Moloney murine leukaemia virus
reverse transcriptase RNase H minus (Promega, Madison, WI) in a
total volume of 50 ml of the manufacturer’s buffer for 1 h at 42uC
and10 minat70uC.Real-timePCRwasperformedusingtheSYBR
Green kit (Stratagene Brilliant II) and analyzed using the MxPro
software (Stratagene, La Jolla, CA). The following primers were
used. Proximal promoter of IL-8 (ppIL-8): sense 59-AGTGTGAT-
GACTCAGGTTTGCCCT-3; anti-sense 59-AAGCTTGTGT-
GCTCTGCTGTCTCT-39; proximal promoter of GAPDH
(ppGAPDH): sense 59 TCCCATCACCATCTTCCAGG-39, anti-
sens 59-CATCGCCCCACTTGATTTTG-39. Proximal promoter
of KC (ppKC): sense 59-GGAGCTCTGGAGTTTCGAGCA-
TAA-3; anti-sense 59-AGTCTGGAGTGCTGGAACTGGTTA-
39;K C - 7 k b :s e n s e5 9-TTCAAGCAGCCTCTCCCAGATC-
AA-39, antisense 59-CATTTGCCAGTCCTTTGTGGCTGA-39.
hCD44ex2: sense 59-TGCCGCTTTGCAGGTGTATT-39, anti-
sense 59-GGCAAGGTGCTATTGAAAGCCT-39,m C D 4 4 e x 2 :
sense 59-TTTGAATGTAACCTGCCGCTACGC-39, antisense
59-AGGTACTGTTGAAAGCCTGGCAGA-39. The PCR condi-
tions were: 95uC 10 min, and 45 cycles at 94uC1 5 0 60uC3 0 0 72uC
200, followed by the dissociation curve program for the analysis of
the PCR products.
Chromatin immunoprecipitation (ChIP)
Formaldehyde-fixed human Beas-2B and mouse MLE-15 cells
were extracted to remove unfixed components. The average size of
sonicated chromatin was approximately 500 base pairs, allowing
analysis of the PCR products (150 base pairs; data not shown).
Sonicated chromatin corresponding to 5.10
6 cells was immuno-
precipitated with 8 mg of irrelevant IgG or specific antibodies as
indicated in corresponding figures. After extensive washing and
reversed crosslinking, nucleic acids were used for quantitative real-
time PCR, done with SYBR Green kits as detailed above.
Control of cell viability
Cell viability was checked by the trypan blue dye exclusion test.
Cell lysis was controlled measuring the release of lactate
dehydrogenase (LDH) activity using a commercial kit from
Boehringer (Mannheim, Germany).
Statistical analysis
Data are expressed as the means6S.E.M. and statistical
analyses were performed using an unpaired Student’s t test or
an ANOVA test. Statistical significances are indicated as *
P,0.05; ** p,0.01; *** p,0.001.
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